An RNA replicon system to investigate promising inhibitors of feline coronavirus
Journal of Virology · 20.02.2024 · 98 (2)
DOI: 10.1128/jvi.01216-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 20.02.2024. Verfasst von Kimberly Schmied und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology and Immunology (IVI), Bern and Mittelhäusern, Switzerland. Hauptthemen laut MEDLINE: Antiviral Agents, Coronavirus, Feline, Feline Infectious Peritonitis, Lactams. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF), Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
FIPV is of great significance in the cat population around the world, causing 0.3%–1.4% of feline deaths in veterinary practices (2). As there are neither effective preventive measures nor approved treatment options available, there is an urgent need to identify antiviral drugs against FIPV. Our FCoV replicon system provides a valuable tool for drug discovery in vitro . Due to the lack of cell culture systems for serotype I FCoVs (the serotype most prevalent in the feline population) (2), a different system is needed to study these viruses. A viral replicon system is a valuable tool for studying FCoVs. Overall, our results demonstrate the utility of the serotype I feline coronavirus replicon system for antiviral screening as well as to study this virus in general. We propose several compounds representing promising candidates for future clinical trials and ultimately with the potential to save cats suffering from FIP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Virology and Immunology (IVI), Bern and Mittelhäusern, Switzerland.
- Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
- Institute of Virology, Justus Liebig University Giessen, Giessen, Germany.
- Multidisciplinary Center for Infectious Diseases (MCID), University of Bern, Bern, Switzerland.
- European Virus Bioinformatics Center (EVBC), Jena, Germany.
- Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
ORCID-Profile: Kimberly Schmied, Rosina Ehmann, Nadine Ebert, Güliz Tuba Barut, Lea Almeida, Jenna N Kelly, Lisa Thomann, Hanspeter Stalder, Reto Lang, Gergely Tekes, Volker Thiel
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Schmied, K., Ehmann, R., Kristen-Burmann, C., Ebert, N., Barut, G. T., Almeida, L., Kelly, J. N., Thomann, L., Stalder, H., Lang, R., Tekes, G., & Thiel, V. (2024). An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of Virology, 98(2). https://doi.org/10.1128/jvi.01216-23
Vancouver
Schmied K, Ehmann R, Kristen-Burmann C, Ebert N, Barut GT, Almeida L, et al. An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of Virology. 2024;98(2). doi:10.1128/jvi.01216-23
BibTeX
@article{Schmied2024,
author = {Schmied, Kimberly and Ehmann, Rosina and Kristen-Burmann, Claudia and Ebert, Nadine and Barut, Güliz Tuba and Almeida, Lea and Kelly, Jenna N and Thomann, Lisa and Stalder, Hanspeter and Lang, Reto and Tekes, Gergely and Thiel, Volker},
title = {An RNA replicon system to investigate promising inhibitors of feline coronavirus},
journal = {Journal of Virology},
year = {2024},
volume = {98},
number = {2},
doi = {10.1128/jvi.01216-23}
}
EUVIMED